Eli Lilly and Co
NYSE:LLY

Watchlist Manager
Eli Lilly and Co Logo
Eli Lilly and Co
NYSE:LLY
Watchlist
Price: 786.23 USD -3.15% Market Closed
Market Cap: 747.3B USD
Have any thoughts about
Eli Lilly and Co?
Write Note

Eli Lilly and Co
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Eli Lilly and Co
Operating Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
ZTS

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Eli Lilly and Co
NYSE:LLY
Operating Income
$14.4B
CAGR 3-Years
25%
CAGR 5-Years
21%
CAGR 10-Years
15%
Johnson & Johnson
NYSE:JNJ
Operating Income
$24.2B
CAGR 3-Years
-1%
CAGR 5-Years
7%
CAGR 10-Years
1%
Bristol-Myers Squibb Co
NYSE:BMY
Operating Income
$11.1B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
13%
Pfizer Inc
NYSE:PFE
Operating Income
$13.1B
CAGR 3-Years
-17%
CAGR 5-Years
63%
CAGR 10-Years
-2%
Merck & Co Inc
NYSE:MRK
Operating Income
$21.7B
CAGR 3-Years
20%
CAGR 5-Years
10%
CAGR 10-Years
10%
Zoetis Inc
NYSE:ZTS
Operating Income
$3.3B
CAGR 3-Years
7%
CAGR 5-Years
11%
CAGR 10-Years
13%

See Also

What is Eli Lilly and Co's Operating Income?
Operating Income
14.4B USD

Based on the financial report for Sep 30, 2024, Eli Lilly and Co's Operating Income amounts to 14.4B USD.

What is Eli Lilly and Co's Operating Income growth rate?
Operating Income CAGR 10Y
15%

Over the last year, the Operating Income growth was 54%. The average annual Operating Income growth rates for Eli Lilly and Co have been 25% over the past three years , 21% over the past five years , and 15% over the past ten years .

Back to Top